The COVID-19 pandemic highlighted an urgent need for efficient, durable, and widely accessible vaccines. This prompted several important innovations in vaccine technology, and researchers continue to ...
A vaccine with University of Washington roots that fights a suite of coronaviruses including COVID-19 and related, deadly ...
Public health recommendations suggest individuals can resume normal activities 5 days after symptom cessation. However, our study finds that full recovery can take longer, indicating that delayed ...
The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.
As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts ...
WASHINGTON, DC - DECEMBER 06: Dr. Vinay Prasad currently directs the FDA's Center for Biologics Evaluation and Research. (Photo by Marvin Joseph/The Washington Post via Getty Images) Dr. Vinay Prasad, ...
Dear Dr. Roach: You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the risks. I know the risks are based on data. But I wonder how ...
Children who were vaccinated against Covid-19 last season had a “substantially lower risk” of emergency department and urgent care visits related to the virus, according to a report published Thursday ...
The Food and Drug Administration (FDA) is investigating whether the COVID-19 vaccines were associated with any deaths across all age ranges. “FDA is doing a thorough investigation, across multiple age ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. While extensive studies have found Covid-19 vaccines to be safe, effective, and to ...
Introduction: Testing remains one of the most effective strategies for reducing the spread of COVID-19. COVID-19 rapid antigen tests are well-suited for at-home use; however, several barriers, ...
"In this study, the 2023-2024 COVID-19 vaccines were associated with fewer cases of medically attended COVID-19, with more robust outcomes for critical illness; however, VE waned over time, supporting ...